23andMe, founded in 2006 and based in South San Francisco, California, is a biotechnology company specializing in direct-to-consumer genetic testing. Its core mission is to help individuals understand their genetic makeup and its implications for ancestry and health. Customers provide saliva samples, which are analyzed to generate detailed reports on ancestry and genetic predispositions to various health conditions. The company's name reflects the 23 pairs of chromosomes in human DNA.
Notable figures associated with 23andMe include co-founder Anne Wojcicki. The company has attracted significant investment from entities like Google Ventures. Key achievements include becoming the first FDA-approved direct-to-consumer genetic test for health risks and traits. 23andMe has had a substantial impact by democratizing access to genetic information, empowering millions of users with insights into their heritage and potential health risks.
